1.31 USD
▲+0.02+4.80%
盘后 1.26 +0.80%
2026-08-03
市值
$443.46M
市盈率
—
EPS
-0.23
股息率
—
52 周区间
0.93 – 2.73
成交量
6.55M
Beta
2.18
目标价
11.43
52W 低 0.9352W 高 2.73
价格走势
公司简介
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under ...